Bo-Kyoung Kim1, Yoon-Ho Choi2, Yun-Mi Song3, Joo-Hyun Park4, Hye-Mi Noh5, Tuong L Nguyen6, John L Hopper7. 1. Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea. 2. Center for Health Promotion, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Electronic address: yh38.choi@samsung.com. 3. Department of Family Medicine, Samsung Medical Center and Center for Clinical Research, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Seoul, Korea. Electronic address: yunmisong@skku.edu. 4. Health Care Center, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea. 5. Department of Family Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea. 6. Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, University of Melbourne, Carlton, Victoria, Australia. 7. Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, University of Melbourne, Carlton, Victoria, Australia; Department of Epidemiology and Institute of Health and Environment, School of Public Health, Seoul National University, Seoul, Korea.
Abstract
PURPOSE: Bone mineral density (BMD) may be useful as a surrogate marker reflecting lifetime exposure to estrogen in a woman. Our study aimed to investigate an association between BMD and breast cancer risk. METHODS: A case-control study was conducted using 253 breast cancer cases and 506 age and menopausal status-matched controls from the same institution. Cases were ascertained through medical record review of the women with abnormal mammographic findings. BMD was measured at the lumbar spine and femoral neck using a dual-energy X-ray absorptiometry. The association was estimated by conditional logistic regression analysis with an adjustment for covariates. RESULTS: Although there was no difference in the association between pre- and postmenopausal disease, the association between BMD and breast cancer was evident for postmenopausal breast cancer. One standard deviation in age and menopausal status adjusted BMD at lumbar spine and femur neck was associated with 1.35-fold (standard error = 0.19, P = .04) and 1.34-fold (standard error = 0.20, P = .05) increased likelihood of breast cancer risk, respectively, for postmenopausal women. CONCLUSION: After adjusting for covariates, higher BMD at lumbar spine and femur neck are associated with increased likelihood of breast cancer risk for postmenopausal women. These findings suggest that BMD could be included in breast cancer risk prediction models for postmenopausal Korean women.
PURPOSE: Bone mineral density (BMD) may be useful as a surrogate marker reflecting lifetime exposure to estrogen in a woman. Our study aimed to investigate an association between BMD and breast cancer risk. METHODS: A case-control study was conducted using 253 breast cancer cases and 506 age and menopausal status-matched controls from the same institution. Cases were ascertained through medical record review of the women with abnormal mammographic findings. BMD was measured at the lumbar spine and femoral neck using a dual-energy X-ray absorptiometry. The association was estimated by conditional logistic regression analysis with an adjustment for covariates. RESULTS: Although there was no difference in the association between pre- and postmenopausal disease, the association between BMD and breast cancer was evident for postmenopausal breast cancer. One standard deviation in age and menopausal status adjusted BMD at lumbar spine and femur neck was associated with 1.35-fold (standard error = 0.19, P = .04) and 1.34-fold (standard error = 0.20, P = .05) increased likelihood of breast cancer risk, respectively, for postmenopausal women. CONCLUSION: After adjusting for covariates, higher BMD at lumbar spine and femur neck are associated with increased likelihood of breast cancer risk for postmenopausal women. These findings suggest that BMD could be included in breast cancer risk prediction models for postmenopausal Korean women.
Authors: Dagmar Schaffler-Schaden; Christoph Kneidinger; Gregor Schweighofer-Zwink; Maria Flamm; Bernhard Iglseder; Christian Pirich Journal: Skeletal Radiol Date: 2020-01-24 Impact factor: 2.199
Authors: Merav Fraenkel; Victor Novack; Yuval Mizrakli; Michael Koretz; Ethel Siris; Larry Norton; Tali Shafat; David B Geffen Journal: NPJ Breast Cancer Date: 2022-02-17
Authors: Tuong Linh Nguyen; Ye Kyaw Aung; Christopher Francis Evans; Choi Yoon-Ho; Mark Anthony Jenkins; Joohon Sung; John Llewelyn Hopper; Yun-Mi Song Journal: Breast Cancer Res Date: 2015-11-18 Impact factor: 6.466